Brimonidine 0.33% gel

DRUG2 trials

Sponsors

The Hospital for Sick Children, Istanbul Training and Research Hospital

Conditions

Capillary MalformationsRosaceaRosacea Subtype 1 (Erythematotelangiectatic)

Phase 3

Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations

TerminatedNCT02764411

The Hospital for Sick ChildrenCapillary Malformations

Start: 2016-06-30End: 2018-10-31Updated: 2019-04-16

Phase 4

Brimonidine 0.33% for Rosacea-Related Facial Erythema

CompletedNCT07431476

Istanbul Training and Research HospitalRosacea, Rosacea Subtype 1 (Erythematotelangiectatic)

Start: 2025-05-01End: 2025-08-07Updated: 2026-02-24